Skip to content

JDOC vs TMED

JPMorgan Healthcare Leaders ETF

JDOCCNasdaq

T. Rowe Price Health Care ETF

TMEDANasdaq

Overlap

Expense ratio

TMED −0.21pt a year

JDOC0.65%TMED0.44%

Avg volume · 30D

TMED 19.1×the volume

JDOC389TMED7.43K

JDOC vs TMED Performance

Oct 31, 2025 – Nov 2, 2026

+20.3%JDOC+19.9%TMED

Oct 31, 2025 to Nov 2, 2026. JDOC +20.3%. TMED +19.9%. Use the arrow keys to read each point.0%5%10%25%30%Oct 2025May 2026Nov 2026
Expense ratio
JDOC 0.65%
TMED 0.44%, better
Fund size
JDOC $10M
TMED $34M
1Y total return
JDOC +20.3%, better
TMED +19.9%
Yield (12M)
JDOC 0.78%
TMED No data
Holdings
JDOC 56
TMED 112
Avg volume (30D)
JDOC 389 sh
TMED 7.43K sh, better
NAV per share
JDOC $65.60
TMED $34.31
52W range

ETF.net Grade

JDOC: Cost 43, Risk 64, Mission not scored, Tradability 4, Holdings 57, Durability 40. TMED: Cost 82, Risk 55, Mission not scored, Tradability 59, Holdings 91, Durability 35.
Pillar letters and Scores for JDOC, TMED, with each pillar’s weight
PillarJDOCTMED
Cost30% weightC43A82Higher
Mission25% weightNot scoredNot scored
Risk15% weightB64HigherB55
Tradability15% weightF4B59Higher
Holdings10% weightB57A91Higher
Durability5% weightC40HigherD35

Rank among US Active Sector funds

Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. JDOC and TMED are both graded against the same 35 US Active Sector funds, so their Grades compare head to head.

US Active Sector⁠

Category · 35 funds
See all 35 ›

TMED ranks 2nd and JDOC 23rd of 35 funds in the US Active Sector Category.

  1. Rank 1AAVREAvantis Real Estate ETFScore 77
  2. Rank 2APSRInvesco Active U.S. Real Estate ETFScore 70
  3. Rank 2ATMEDT. Rowe Price Health Care ETFScore 70
  4. Rank 4BTRUTVanEck Technology TruSector ETFScore 69
  5. Rank 22CJPREJPMorgan Realty Income ETFScore 44
  6. Rank 23CJDOCJPMorgan Healthcare Leaders ETFScore 41
  7. Rank 24CDPREVirtus Duff & Phelps Real Estate Income ETFScore 40

Our read on each fund

ETF.net Research

JDOCCJPMorgan Healthcare Leaders ETF

TMEDAT. Rowe Price Health Care ETF

In short

JDOC Most healthcare ETFs just buy the sector list. JDOC is the stock-picker's version: about 60 names chosen by J.P. Morgan healthcare specialists hunting companies whose future growth the market underrates, with the whole globe in bounds.

TMED No data

Stated mandate

JDOC Seeks long-term capital appreciation by investing primarily in healthcare companies that the adviser considers leaders, particularly where future growth is underappreciated by the market.

TMED No data

Why people hold it

  • JDOC Concentrated by design: about 60 healthcare stocks rather than the full sector roster, so the managers' picks actually shape the portfolio.jpmorgan.com
  • The mandate is global, so European and Asian drugmakers and device firms are as eligible as US-listed ones.jpmorgan.com
  • Run by J.P. Morgan portfolio managers who specialize in healthcare inside its equity research groups, leaning on the firm's global bench of sector analysts.sec.govjpmorgan.com
  • 0.65% a year for specialist active research sits right at the median fee for actively managed US equity ETFs, not a markup for the J.P. Morgan name.

TMED No data

Worth knowing

  • JDOC A small fund that trades thinly since its 2023 launch, so spreads can run wider than on the giant healthcare index ETFs and execution matters more.
  • One sector, roughly 60 names. Drug pricing rules, patent cliffs and trial outcomes land harder here than in a diversified fund.prnewswire.com
  • Broad active core rivals like DFAC and AVLC charge under 0.2% for far wider portfolios. JDOC's fee reflects a narrow specialist mandate, not a core holding's price.

TMED No data

Full JDOC profile⁠

Full TMED profile⁠

JDOC vs TMED Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

JDOC vs TMED Cost

Overpaying JDOC vs TMED

$3,865

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • JDOC 0.65%

    $12,717

  • TMED 0.44%

    $8,852

$10,000
30 years

Cost over time

  • JDOC 0.65%
  • TMED 0.44%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K051015202530JDOC $12,717TMED $8,852

Year by year

YearJDOCTMEDOverpaying
10$1,163$794$369
20$4,440$3,061$1,379
30$12,717$8,852$3,865

Expense ratio

  • 0.65%JDOC
  • 0.44%TMED, cheaper
  • Middle half of US Active Sector funds
  • Median 0.61%

TMED 7th cheapest of 35 funds

JDOC 19th cheapest of 35 funds

JDOC vs TMED Dividends

Last 12 months to Nov 2, 2026
Yield (12M)
JDOC 0.78%
TMED No data
Payout (12M)
JDOC $0.51
TMED No data
Last payment
JDOC $0.51
TMED $0.16
Ex-dividend
JDOC Dec 16, 2025
TMED Dec 23, 2025
Paid on
JDOC Dec 18, 2025
TMED Dec 26, 2025
Frequency
JDOC Annual
TMED Irregular

Distribution history

Per share, 2023 to 2026, same scale for both

JDOCAnnual · 4 paymentsAll JDOC payments⁠
One bar per payment. 4 payments from 2023 to 2026 YTD. Dec 19, 2023 $0.08; Dec 16, 2024 $2.49; Dec 24, 2024 $0.33; Dec 16, 2025 $0.51. Use the arrow keys to read each point.$0$2.5020232026YTD
TMEDIrregular · 1 paymentAll TMED payments⁠
One bar per payment. 1 payment from 2023 to 2026 YTD. Dec 23, 2025 $0.16. Use the arrow keys to read each point.$0$2.5020232026YTD

JDOC vs TMED Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years
JDOC 14.3%since Dec 2023TMED 14.7%since Jul 2025
Return per unit of riskSharpe ratio, 3 years
JDOC 0.52since Dec 2023TMED 1.50since Jul 2025
Worst fallMax drawdown, 5 years
JDOC −20.8%since Nov 2023TMED −11.1%since Jun 2025
Market sensitivityBeta, 5 years
JDOC 0.47TMED 0.46

Popular comparisons

  • JDOCCvsAVREA

    JPMorgan Healthcare Leaders ETF · Avantis Real Estate ETF

    Expense ratio
    0.65% · 0.17%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • TMEDAvsAVREA

    T. Rowe Price Health Care ETF · Avantis Real Estate ETF

    Expense ratio
    0.44% · 0.17%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • JDOCCvsPSRA

    JPMorgan Healthcare Leaders ETF · Invesco Active U.S. Real Estate ETF

    Expense ratio
    0.65% · 0.35%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • TMEDAvsPSRA

    T. Rowe Price Health Care ETF · Invesco Active U.S. Real Estate ETF

    Expense ratio
    0.44% · 0.35%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • JDOCCvsTRUTB

    JPMorgan Healthcare Leaders ETF · VanEck Technology TruSector ETF

    Expense ratio
    0.65% · 0.14%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
  • TMEDAvsTRUTB

    T. Rowe Price Health Care ETF · VanEck Technology TruSector ETF

    Expense ratio
    0.44% · 0.14%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.